Skip to content

Improvement of Lower Digestive Endoscopy Without Anesthesia : Evaluation of the Virtual Reality Mask

Amélioration du Taux de succès de la Coloscopie Totale Lors Des Endoscopies Digestives Sans anesthésie : évaluation du Masque de réalité Virtuelle

Status
Not yet recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06414239
Acronym
REVENDO
Enrollment
240
Registered
2024-05-16
Start date
2024-06-30
Completion date
2026-12-31
Last updated
2024-05-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Digestive System Disease

Keywords

Lower digestive endoscopy whatever the indication, Digestive endoscopy, Colonoscopy, Virtual reality

Brief summary

90% of colonoscopies are performed with general anesthesia (GA). GA carries risks and requires a prior anesthesia consultation, a dedicated team and technical platform on the day of the examination. These constraints increase the time it takes to organize examinations. This was particularly highlighted during the recent health crisis. The success of colonoscopy without GA varies depending on the patient's experience of the examination. Any measure allowing better tolerance of the exam is therefore likely to increase its success rate and avoid rescheduling the exam under GA. A 2017 meta-analysis showed that the use of virtual reality (VR) reduced pain and anxiety during care for burn victims, in trauma and oncology. In upper digestive endoscopy, retrospective studies have shown good tolerability of the examinations and a reduction in pain compared to patients with only local anesthesia. Thus, if the VR mask improves the success rate of total colonoscopy by improving tolerance and acceptability, more examinations without GA could be considered. It could also have an economic impact.

Interventions

DEVICEUse of a VR mask

Virtual reality mask

OTHERStandard of care

Without any premedication or anesthesia

Sponsors

Assistance Publique - Hôpitaux de Paris
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
DIAGNOSTIC
Masking
NONE

Intervention model description

Randomized 1:1

Eligibility

Sex/Gender
ALL
Age
18 Years to 100 Years
Healthy volunteers
No

Inclusion criteria

Patient over 18 years old with an indication for total colonoscopy and accepting without General Anesthesia

Exclusion criteria

* Hearing problems or low vision * Psychiatric or cognitive disorders hindering communication * History of epilepsy * Claustrophobia which can lead to a rejection of the virtual reality mask * History of cybercynetosis during previous use of VR * Chronic abdominal pain with baseline Visual analogue scale (VAS) \> 5 * Emergency examination * Patient participating in another interventional research on digestive endoscopy * Patient not speaking French * Patient under guardianship

Design outcomes

Primary

MeasureTime frameDescription
Rate of cecal intubationAt day 0Success of a total colonoscopy defined by the rate of cecal intubation (visualization of the ileocecal valve and the appendicular orifice with the endoscope located near the appendicular orifice) or visualization of the ileocecal anastomosis in case of history of surgery removing the ileocaecal valve

Secondary

MeasureTime frameDescription
Maximum pain assessed by the patient by numerical scaleAt day 0The scale varies from 0 to 10. 0 is no pain, 10 is the worst possible pain
Maximum anxiety assessed by the patient by numerical scaleAt day 0The scale varies from 0 to 10. 0 is no anxiety, 10 is the worst possible anxiety
Patient's opinion to repeat the examination under the same conditionsAt day 0It will be assesses by the Likert scale
Duration of the examinationAt day 0Time between introduction and removal of the colonoscope
Number of minutes from visualization of the valve between the introduction of the colonoscope and 30 minutes maximumAt day 0Between the introduction of the colonoscope and 30 minutes maximum. It can be the ileum in the event of a history of surgery removing the valve.
Total duration of the procedureAt day 0time between entering and leaving the room
Proportion of colonoscopies with detection of at least one adenomaUp to 30 months
Proportion of VR device malfunctions (≥ 1) during the procedure in the intervention groupUp to 30 months
Operator satisfactionUp to 30 monthsAssessed by the Analogue Visual Scale examination
Incremental cost effectiveness ratio or incremental cost-result ratio in the form of cost per additional colonoscopic successUp to 30 months
Proportion of procedures where the VR mask is removed at the patient's requestUp to 30 months

Contacts

Primary ContactMy-Linh TRAN-MINH, Dr
mylinh.tranminh@aphp.fr+33142499597
Backup ContactJérôme Lambert, Pr
jerome.lambert@u-paris.fr+33142499742

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026